2022
DOI: 10.1039/d2ra05216d
|View full text |Cite
|
Sign up to set email alerts
|

Development of a hematite nanotube and tyramine-based drug carrier against drug-resistant bacteria Klebsiella pneumoniae

Abstract: In this study, hematite nanotube (HNT) and tyramine-based advanced nano-drug carriers were developed for inhibiting the growth of Klebsiella pneumoniae (K. pneumoniae).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Perovskites, particularly the perovskite‐type NPs that we studied in our work, are discovered to be utilised in numerous biological applications, though [75–77]. This can be attributed to their large surface area and their relatively low toxic effects.…”
Section: Resultsmentioning
confidence: 92%
“…Perovskites, particularly the perovskite‐type NPs that we studied in our work, are discovered to be utilised in numerous biological applications, though [75–77]. This can be attributed to their large surface area and their relatively low toxic effects.…”
Section: Resultsmentioning
confidence: 92%
“…12 Hematite nanoparticles have been synthesized in different shapes, such as ellipsoids, spheres, and cubes. 13 Researchers have started to explore hematite nanocarriers 14,15 as drug carriers as there are several drawbacks associated with other metallic nanoparticles (gold, silver), such as cellular toxicity induced by accumulation, poor biodistribution, poor or rapid clearance, less colloidal stability, and a poor cellular uptake rate. However, the field of using hematite nanomaterials as drug carrier vehicles is still in its infancy.…”
Section: Introductionmentioning
confidence: 99%